STOCK TITAN

Maravai LifeSciences Announces March 2024 Investor Conference Schedule

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary
Maravai LifeSciences, Inc. (MRVI) will participate in the KeyBanc Capital Markets Life Sciences and MedTech Investor Forum on March 19, 2024. Trey Martin, CEO, will engage in a fireside chat at 11:15 a.m. PDT. The event will be virtually broadcasted on the company's Investor Relations website.
Positive
  • None.
Negative
  • None.

SAN DIEGO, March 12, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the following investor conference during the month of March.

On March 19, 2024, at 11:15 a.m. PDT, Trey Martin, Chief Executive Officer will participate in a fireside chat at the KeyBanc Capital Markets Life Sciences and MedTech Investor Forum being held virtually.

A live webcast of the presentation will be available to all interested parties on the Maravai LifeSciences Investor Relations website, under News & Events, Upcoming events. An archived version of the webcast will also be available on the Maravai website after the event is completed.

About Maravai

Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologics safety testing to many of the world’s leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapies companies.

For more information about Maravai LifeSciences, visit www.maravai.com.


Maravai LifeSciences (MRVI) is scheduled to participate in the KeyBanc Capital Markets Life Sciences and MedTech Investor Forum on March 19, 2024.

Trey Martin, the Chief Executive Officer of Maravai LifeSciences (MRVI), will be participating in the fireside chat at the KeyBanc Capital Markets Life Sciences and MedTech Investor Forum.

Interested parties can watch the live webcast of the presentation by Maravai LifeSciences (MRVI) at the investor conference on the company's Investor Relations website, under News & Events, Upcoming events.

Yes, an archived version of the webcast will be available on the Maravai website after the event is completed.
Maravai LifeSciences Holdings Inc

NASDAQ:MRVI

MRVI Rankings

MRVI Latest News

MRVI Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Commercial Services, Miscellaneous Commercial Services
US
San Diego

About MRVI

maravai lifesciences catalyzes the growth of successful, entrepreneurial life science companies by providing expertise, capital, processes and systems so that they can continue to serve scientists who are striving to improve human health. current maravai lifesciences portfolio companies provide enabling tools and services in the life sciences research and bioproduction industries that accelerate breakthrough discoveries in areas such as genomics, proteomics, and biotherapeutic development. maravai lifesciences was formed in march 2014 through a partnership with gtcr, a leading private equity firm. our mission is to build a transformative life sciences reagents company by acquiring outstanding businesses and accelerating their growth. since our founding, we have acquired four companies, each a leader in its market segment. vector laboratories has led the market for labeling and detection products used by researchers in immunohistochemistry, immunofluorescence and related techniques. tri